Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
Top Cited Papers
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (1) , 90-97
- https://doi.org/10.1111/j.1538-7836.2005.01697.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulationJournal of Thrombosis and Haemostasis, 2004
- Hemostatic markers and the sepsis‐related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unitAmerican Journal of Hematology, 2004
- Coagulopathy of sepsisThrombosis and Haemostasis, 2004
- Disseminated Intravascular Coagulation in SepsisSeminars in Thrombosis and Hemostasis, 2001
- Disseminated Intravascular CoagulationNew England Journal of Medicine, 1999
- Review: Infectious Diseases and Coagulation DisordersThe Journal of Infectious Diseases, 1999
- ANTITHROMBIN III SUPPLEMENTATION IN SEVERE SEPSISShock, 1997
- Substitution of antithrombin III in shock and DIC: A randomized studyThrombosis Research, 1985
- ANTITHROMBIN-III TRANSFUSION IN DISSEMINATED INTRAVASCULAR COAGULATIONThe Lancet, 1978
- Heparin therapy in bacterial septicemiaThe Journal of Pediatrics, 1977